Skip to the page

Data / Drug companies / Hydralazine hydrochloride

Hydralazine hydrochloride: 47 companies and 144 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Hydralazine hydrochloride is listed in the FDA National Drug Code Directory by 47 companies, with 144 products in commercial distribution. 144 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; injection; tablet, film coated, and the newest product started marketing on September 14, 2026.

The request: Get every company that lists hydralazine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
47
Products
144
Generic (ANDA) products
144 (100.0%)
Application numbers
21
Routes
Oral, Intramuscular, Intravenous
openFDA record search
api.fda.gov

Companies that list hydralazine hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Cardinal Health 107, LLC9tablet; injectionGeneric drugs (ANDA)September 14, 2026
Bryant Ranch Prepack7tabletGeneric drugs (ANDA)May 26, 2017
Bryant Ranch Prepack7tabletGeneric drugs (ANDA)May 26, 2017
Remedyrepack Inc.7tablet; injectionGeneric drugs (ANDA)June 3, 2025
A-S Medication Solutions6tabletGeneric drugs (ANDA)May 26, 2017
Bryant Ranch Prepack5tabletGeneric drugs (ANDA)May 26, 2017
Coupler LLC5tabletGeneric drugs (ANDA)August 7, 2026
Ascend Laboratories, LLC4tabletGeneric drugs (ANDA)May 24, 2010
Camber Pharmaceuticals, Inc.4tabletGeneric drugs (ANDA)January 1, 2010
Chartwell RX, LLC4tablet, film coatedGeneric drugs (ANDA)April 6, 2007
Exelan Pharmaceuticals Inc.4tabletGeneric drugs (ANDA)May 20, 2016
Fresenius Kabi USA, LLC4injectionGeneric drugs (ANDA)January 31, 2011
Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.4tabletGeneric drugs (ANDA)August 2, 2023
Macleods Pharmaceuticals Limited4tabletGeneric drugs (ANDA)August 26, 2024
Major Pharmaceuticals4tabletGeneric drugs (ANDA)January 3, 2025
Medical Purchasing Solutions, LLC4injection; injection, solutionGeneric drugs (ANDA)February 13, 2023
Radha Pharmaceuticals, Inc.4tabletGeneric drugs (ANDA)March 4, 2021
ScieGen Pharmaceuticals, Inc.4tabletGeneric drugs (ANDA)May 26, 2017
Strides Pharma Science Limited4tabletGeneric drugs (ANDA)June 30, 2022
Teva Pharmaceuticals USA, Inc.4tabletGeneric drugs (ANDA)September 30, 1990
American Health Packaging3tabletGeneric drugs (ANDA)September 15, 2024
Aphena Pharma Solutions - Tennessee, LLC3tabletGeneric drugs (ANDA)March 4, 2021
Cadila Pharmaceuticals Limited3tabletGeneric drugs (ANDA)December 29, 2015
HF Acquisition Co LLC, DBA HealthFirst3injection; injection, solutionGeneric drugs (ANDA)December 9, 2019
Modavar Pharmaceuticals LLC3tabletGeneric drugs (ANDA)December 29, 2015
Mylan Institutional Inc.3tabletGeneric drugs (ANDA)December 26, 2007
NuCare Pharmaceuticals,Inc.3tabletGeneric drugs (ANDA)January 1, 2010
Safecor Health, LLC3tabletGeneric drugs (ANDA)March 6, 2026
Aphena Pharma Solutions - Tennessee, LLC2tabletGeneric drugs (ANDA)May 20, 2016
Proficient Rx LP2tabletGeneric drugs (ANDA)June 30, 2013
Proficient Rx LP2tabletGeneric drugs (ANDA)August 2, 2023
American Regent, Inc.1injection, solutionGeneric drugs (ANDA)June 30, 1997
Aphena Pharma Solutions - Tennessee, LLC1tabletGeneric drugs (ANDA)September 30, 1990
Baxter Healthcare Corporation1injectionGeneric drugs (ANDA)July 17, 2025
Civica, Inc.1injection, solutionGeneric drugs (ANDA)October 29, 2020
Eugia US LLC1injectionGeneric drugs (ANDA)February 13, 2023
Henry Schein, Inc.1injectionGeneric drugs (ANDA)April 10, 2025
Hikma Pharmaceuticals USA Inc.1injection, solutionGeneric drugs (ANDA)December 18, 2020
Meitheal Pharmaceuticals Inc.1injectionGeneric drugs (ANDA)June 2, 2025
NCS HealthCare of Ky, LLC DBA Vangard Labs1tabletGeneric drugs (ANDA)January 1, 2010
Navinta LLC1injectionGeneric drugs (ANDA)November 25, 2025
Northwind Health Company, LLC1tabletGeneric drugs (ANDA)February 15, 2024
PD-Rx Pharmaceuticals, Inc.1tablet, film coatedGeneric drugs (ANDA)April 6, 2007
Preferred Pharmaceuticals Inc.1tabletGeneric drugs (ANDA)October 5, 2021
ProPharma Distribution1injectionGeneric drugs (ANDA)January 31, 2011
Proficient Rx LP1tablet, film coatedGeneric drugs (ANDA)April 6, 2007
Zydus Pharmaceuticals USA Inc.1injectionGeneric drugs (ANDA)April 28, 2025

Dosage forms

Dosage formProductsShare
Tablet11479.2%
Injection1913.2%
Tablet, film coated64.2%
Injection, solution53.5%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)144100%

Pharmacologic classes

ClassProducts
Arteriolar Vasodilator144

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.